Related references
Note: Only part of the references are listed.Loci for insulin processing and secretion provide insight into type 2 diabetes risk
K. Alaine Broadaway et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2023)
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches
Verena Zuber et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2022)
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
Vasiliki Lagou et al.
NATURE COMMUNICATIONS (2021)
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis
Apostolos Tsapas et al.
DIABETES OBESITY & METABOLISM (2021)
Advancing the use of genome-wide association studies for drug repurposing
William R. Reay et al.
NATURE REVIEWS GENETICS (2021)
Use of dipeptidyl peptidase-4 inhibitors is associated with a lower risk of rheumatoid arthritis in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies
Nipith Charoenngam et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis
Gorica G. Ristic et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Association between thiazolidinedione use and rheumatoid arthritis risk in patients with type II diabetes, a population-based, case-control study
Ming-Shun Hsieh et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study
M. E. Naffaa et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
Exenatide ameliorates inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes
Yunxia Tao et al.
IUBMB LIFE (2019)
Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017
Saeid Safiri et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
CURRENT DIABETES REPORTS (2019)
The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes
Xingye Du et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019
Annalisa Buniello et al.
NUCLEIC ACIDS RESEARCH (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Ontology and Function of Fibroblast-Like and Macrophage-Like Synoviocytes: How Do They Talk to Each Other and Can They Be Targeted for Rheumatoid Arthritis Therapy?
Jiajie Tu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
Venexia M. Walker et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
Arun Chaudhury et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Functional role of PPAR-γ on the proliferation and migration of fibroblast- like synoviocytes in rheumatoid arthritis
Xiao-Feng Li et al.
SCIENTIFIC REPORTS (2017)
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
Robert A. Scott et al.
DIABETES (2017)
Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease
Connor A. Emdin et al.
DIABETES (2017)
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants
Mitchell J. Machiela et al.
BIOINFORMATICS (2015)
New genetic loci link adipose and insulin biology to body fat distribution
Dmitry Shungin et al.
NATURE (2015)
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke et al.
NATURE (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Inequities in access to biologic and synthetic DMARDs across 46 European countries
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
K. -D. Lin et al.
DIABETIC MEDICINE (2014)
UK Biobank Data: Come and Get It
Naomi E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2013)
Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial
Michelle J. Ormseth et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy-a pilot study
Alessandra Palma et al.
RHEUMATOLOGY (2012)
Avoiding bias from weak instruments in Mendelian randomization studies
Stephen Burgess et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Josee Dupuis et al.
NATURE GENETICS (2010)
Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel
Kevin S. C. Hamming et al.
DIABETES (2009)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
P. A. Sarafidis et al.
KIDNEY INTERNATIONAL (2006)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
GD Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
D Altshuler et al.
NATURE GENETICS (2000)
Share Paper
